The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Pharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
Distinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717
Furchgott, R. F., & Bursztyn, P. (1967) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1967.tb53817.x · Cited by 522
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
Lawler, C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00099-2 · Cited by 408
Kikuchi, T., Tottori, K., Uwahodo, Y., Hirose, T., Miwa, T., Oshiro, Y., & Morita, S. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10600-9 · Cited by 276
Self-citationReceptor Occupancy and Tissue Response
NICKERSON, M. (1956) · Nature · doi:10.1038/178697b0 · Cited by 242
Partial agonists, full agonists, antagonists: dilemmas of definition
Hoyer, D., & Boddeke, H. W. G. M. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90129-8 · Cited by 237
Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions
Wang, Y., Xu, R., Sasaoka, T., Tonegawa, S., Kung, M.-P., & Sankoorikal, E.-B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08305.2000 · Cited by 195
Senogles, S. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31628-9 · Cited by 191
Effect of guanine nucleotides on striatal dopamine receptors
ZAHNISER, N. R., & MOLINOFF, P. B. (1978) · Nature · doi:10.1038/275453a0 · Cited by 184
Self-citationAlternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins
Guiramand, J., Montmayeur, J.-P., Ceraline, J., Bhatia, M., & Borrelli, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7354 · Cited by 168
De Lean, A., Kilpatrick, B. F., & Caron, M. G. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15148-1 · Cited by 159
WREGGETT, K. A., & Léan, A. D. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15078-5 · Cited by 151
Hamblin, M. W., & Creese, I. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90423-x · Cited by 135
Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Meller, E., Bohmaker, K., Namba, Y., Friedhoff, A. J., & Goldstein, M. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10474-4 · Cited by 134
Lack of Discrimination by Agonists for D2 and D3 Dopamine Receptors
Burris, K. D., Pacheco, M. A., Filtz, T. M., Kung, M.-P., Kung, H. F., & Molinoff, P. B. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00099-l · Cited by 108
Self-citationInoue, A., Miki, S., Seto, M., Kikuchi, T., Morita, S., Ueda, H., Misu, Y., & Nakata, Y. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00920-x · Cited by 105
Self-citationLahti, A. C., Weiler, M. A., Corey, P. K., Lahti, R. A., Carlsson, A., & Tamminga, C. A. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00030-9 · Cited by 104
Semba, J., Watanabe, A., Kito, S., & Toru, M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00059-f · Cited by 93
Inoue, T., Domae, M., Yamada, K., & Furukawa, T. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12799-7 · Cited by 92
Influence of G Protein Type on Agonist Efficacy
Yang, Q., & Lanier, S. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.651 · Cited by 53
Efficacy in drug receptor theory: outdated concept or under-valued tool?
Kenakin, T. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01361-9 · Cited by 51
Boundy, V. A., Lu, L., & Molinoff, P. B. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12363-x · Cited by 51
Self-citationTransdihydrolisuride, a partial dopamine receptor antagonist: Effects on monoamine metabolism
Kehr, W. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90518-1 · Cited by 45
Paradoxical regulation of dopamine receptors in transfected 293 cells.
Filtz, T. M., Artymyshyn, R. P., Guan, W., & Molinoff, P. B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13181-7 · Cited by 40
Self-citationFiltz, T. M., Guan, W., Artymyshyn, R. P., Facheco, M., Ford, C., & Molinoff, P. B. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24044-7 · Cited by 37
Self-citationMomiyama, T., Amano, T., Todo, N., & Sasa, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00350-0 · Cited by 36
Clark, D. T., Hjorth, S., & Carlsson, A. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90694-0 · Cited by 36
Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
Meller, E., Puza, T., Miller, J., Friedhoff, A. J., & Schweitzer, J. W. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24664-x · Cited by 31
Efficacy of aripiprazole in psychotic disorders: Comparison with haloperidol and placebo
Kane, J. M., Ingenito, G. G., & Ali, M. W. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)90383-9 · Cited by 29
Developing novel antipsychotic drugs: Strategies and goals
Miyamoto, S., Duncan, G. E., Mailman, R. B., & Lieberman, J. A. (2000) · Cited by 26
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Metadata
- Authors
- Burris, K. D., Molski, T. F., Xu, C., Ryan, E., Tottori, K., Kikuchi, T., Yocca, F. D., & Molinoff, P. B.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 302
- Issue
- 1
- Pages
- 381-389
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1971179661
- Cited by
- 922
- References
- 35
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.